Cytokinetics Inc (CYTK)

CapEx to Revenue

13.58%

Quarterly · Period ending:

CYTK logo

CYTK CapEx to Revenue

Latest reported13.58%
CYTK Quarterly CapEx/Revenue (0.00% → 13.58%)
High-resolution chart · PNG

CYTK capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Cytokinetics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
13.5802%
30.6381%
31.7882%
483.1612%
6.208%
358.708%
7.621%
530.2376%
769.0763%
210.0599%
4.6053%
58.2011%
82.699%
8.7145%
163.7711%
251.7296%
0.9633%
82.0557%
31.9317%
288.7622%
309.2508%
101.1912%
97.5156%
6.2176%
24.0468%
27.2157%
25.0576%
16.6144%
0.7006%
3.0364%
2.2395%
3.3643%
0.9654%
4.9544%
-4,333.3333%
7.2977%
8.4507%
33.4216%
2.5771%
0.5182%
0.2758%
4.9875%
2.0908%
0.6671%
2.675%
2.9452%
1.1352%
1.0621%
5.4443%
4.1735%
1.035%
1.544%
4.3608%
21.5591%
2.7015%
2.6838%
0.3802%
0.7143%
3.3025%
7.0778%
13.4853%
22.9358%
7.9163%
33.5025%
25.974%
24.7987%
20.6256%
1.2713%
0.0695%
7.115%
0.6345%
2.272%
6.1158%
12.3493%
12.7331%
5.3269%
9.1911%
51.6381%
1,054.8387%
1,733.0189%
67.2891%
65.1408%
9.6082%
22.2102%
15.9761%
18.3904%
12.938%
31.8497%
7.0345%
2.1817%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.